U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Dietary Prevention of Obesity-related Disease Research: Grand Forks, ND
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Plains Area Grand Forks, North Dakota Grand Forks Human Nutrition Research Center Dietary Prevention of Obesity-related Disease Research Research Publications at this Location





- ARS National Programs
- Search for a scientific manuscript
- Search for a research project
- ARS Software
- Programs and Projects
- Collaborations
- Subjects of Investigation
- Publications

Title:   Author  item
                                            Cao, Jayitem
                                            Gregoire, Brianitem
                                            SUN, LI - Mount Sinai Medical Centeritem
                                            SONG, SIHONG - University Of Florida
  Submitted to: Annals of the New York Academy of Sciences
                                    Publication Type: Peer Reviewed Journal
                                    Publication Acceptance Date: 12/14/2011
                                    Publication  Date: 2/4/2012
                                    Citation: Cao, J.J., Gregoire, B.R., Song, S. 2012. Alpha-1 antitrypsin reduces ovariectomy-induced bone loss in mice. Annals of the New York Academy of Sciences. doi: 10.111/j.1749-6632.2011.06370.x.Interpretive Summary: We investigated whether alpha-1 antitrypsin (AAT), a multifunctional protein with proteinase inhibitor and anti-inflammatory activities, mitigates bone loss induced by estrogen deficiency, a state with increased production of proinflammatory cytokines. We found that ovariectomy decreased wet uterus weight, caused significant bone loss, and increased serum leptin concentrations in mice compared to sham. AAT injection (2 mg/mouse, every 3 days for 30 days) increased tibial trabecular bone volume/total volume and trabecular thickness compared to phosphate buffered saline (PBS) injection in ovariectomized mice. Ovariectomized mice with AAT treatment had higher uterus weight, lower serum osteocalcin levels, fewer bone marrow TRAP-positive osteoclasts and less expression of calcitonin receptor in bone than that in PBS-injected mice. We conclude that AAT mitigates ovariectomy-induced bone loss in mice possibly through inhibiting osteoclast activity and bone resorption and AAT can be a potential agent to prevent bone loss in humans.
                                Technical Abstract: Alpha-1antitrypsin (AAT) is a multifunctional protein with proteinase inhibitor and anti-inflammatory activities. Recent studies showed that AAT has therapeutic effect for diseases associated with inflammation, such as type 1 diabetes and arthritis. Proinflammatory cytokines are primary mediators of bone loss in postmenopausal women due to the decreased estrogen production. To determine whether AAT mitigates bone loss induced by estrogen deficiency, thirty-eight female C57BL/6J mice (7-wk-old), were either ovariectomized or sham-operated. Ovariectomized animals were randomly assigned to AAT-injected (n=13; 2 mg/mouse, every 3 days for 30 days) or phosphate buffered saline (PBS)-injected group (n=12), while sham-operated mice (Sham; n=13) were injected with PBS and used as controls. Ovariectomy resulted in decreased wet uterus weight (P<0.01), significant bone loss, increased serum leptin concentrations, and higher body weight (P<0.01) compared to sham. AAT treatment increased tibial trabecular bone volume/total volume and trabecular thickness compared to PBS treatment in ovariectomized mice (P<0.01). Ovariectomized mice with AAT treatment had higher uterus weight (P<0.01), lower serum osteocalcin levels (P<0.05), fewer bone marrow TRAP-positive osteoclasts (P<0.05) and less expression of calcitonin receptor in bone (P<0.01) than that in PBS-injected mice. These data demonstrate that AAT reduces ovariectomy-induced bone loss in mice possibly through inhibiting osteoclast activity and bone resorption. Our results indicated new functions of AAT and imply an novel application of AAT for the treatment of osteoporosis.


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov